Publication date: Available online 30 January 2019
Source: Journal of Oral and Maxillofacial Surgery
Author(s): Joseph E. Cillo., Nicholaus Barbosa
Abstract
Purpose
To present an adalimumab-related dental implant surgical site infection.
Subjects
and Methods: A single case report of a 55-year-old subject with a history of adalimumab biweekly subcutaneous injections for ulcerative colitis who had mandibular extractions and placement of five immediate dental implants.
Results
The subject experienced intra-oral purulent drainage from all five dental implant sites with submental and submandibular space infections two-weeks after surgery. Treatment consisted of extra-oral incision and drainage of involved fascial spaces, removal of all mandibular dental implants and debridement of necrotic mandibular bone. She went onto heal uneventfully.
Conclusion
Individuals taking adalimumab may develop severe infection with loss of implants and bone.
http://bit.ly/2Rnzdwp
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου